← Leaderboards
Yue Wu
Roswell Park Cancer Institute Corp
$1,394,764
Attributed
$2,369,644
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $392.3K · FY2014–20$500K$375K$250K$125K$0
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$2,369,644 · 2
By mechanism
R01$1,949,760 · 1
R21$419,884 · 1
Top collaborators
- Gary J Smith5 shared
Most similar at Roswell Park Cancer Institute Corp
Same institution · by research overlap
- Shipra Gandhi$788,190
Others in their field
Top investigators on “Pre-Clinical Model”
- Dennis R. Burton · Scripps Research Institute$257,157,696
- Leonard Freedman · Leidos Biomedical Research, Inc.$255,997,443
- David Heimbrook · Leidos Biomedical Research, Inc.$96,812,185
- Lynn Briscoe · Leidos Biomedical Research, Inc.$95,451,222
- David M Anderson · University Of Washington$94,243,251
- Ronald B Corley · Boston University Medical Campus$80,765,880
Research focus
Pre-Clinical ModelRecurrenceIn Vivo ModelModalityProstateReceptor SignalingDeprivationIn VivoMalignant Neoplasm Of ProstateMediatingPreventProductionDriving ForceProstate Cancer CellBenignAndrogen MetabolismAndrogen ReceptorInhibitor/AntagonistAndrogensDehydroepiandrosterone SulfateCastrationDehydroepiandrosteroneAdrenal GlandsSource
Grant awards (7)
Prostate-Specific Androgen Transporters are the Missing Target for Complete ADT$392,306
R01 · FY2020 · CA
Prostate-Specific Androgen Transporters are the Missing Target for Complete ADT$380,536
R01 · FY2019 · CA
Prostate-Specific Androgen Transporters are the Missing Target for Complete ADT$392,306
R01 · FY2018 · CA
Prostate-Specific Androgen Transporters are the Missing Target for Complete ADT$392,306
R01 · FY2017 · CA
Prostate-Specific Androgen Transporters are the Missing Target for Complete ADT$392,306
R01 · FY2016 · CA
Deprive prostate cancer of DHEAS to prevent castration-recurrent prostate cancer$229,028
R21 · FY2015 · CA · contact PI
Deprive prostate cancer of DHEAS to prevent castration-recurrent prostate cancer$190,856
R21 · FY2014 · CA · contact PI